News & Events — Leiden Bio Science Park

News

Events

Previous news (15)

Pharming and HAEi International Patient Organization announce partnership with Inceptua Medicines Access for “HAEi Global Access Program”

September 26, 2017
New organisation at the park: Smartnotation

September 25, 2017
ProQR announced positive Top-Line Results from a Phase 1b Study of QR-010 in subjects with Cystic Fibrosis

September 25, 2017
ProQR receives orphan drug designation from FDA for drug candidate QR-313 for Dystrophic Epidermolysis Bullosa

September 19, 2017
Ncardia established following Pluriomics Axiogenesis merger

September 18, 2017
Leiden based VarmX announces publication in Nature: approach to restore blood clotting in patients using anticoagulants inspired by snake venom

September 18, 2017
ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics

September 12, 2017
Pharming announces conclusion of FDA End of Phase 2 interactions on RUCONEST® for Prophylaxis of HAE

September 11, 2017
IGZ and CBG choose Biotech Training Facility for training purposes

September 11, 2017
Startup Officers for direct access to the Dutch Government

September 8, 2017
ProQR’s drug candidate QRX-421 for Usher syndrome receives orphan drug designation from FDA and EMA

September 5, 2017
OmniComm Systems receives EU-U.S. Privacy Shield Certification

August 31, 2017
ProQR completes dosing of Cystic Fibrosis patients in QR-010 phase 1b trial

August 29, 2017
Hercules Pharmaceuticals receives investment from UNIIQ for the development of cancer immunotherapy

August 23, 2017
Pluriomics BV announced cooperation with ACEA Biosciences Inc to advance Cardiovascular drug discovery and the expansion of its services portfolio

August 21, 2017

Future events (15)

Find your job at Leiden Bio Science Park: plenty of challenging jobs available.